Tetanus Prophylaxis Dosing and Administration
The recommended dose of tetanus immune globulin (TIG) is 250 units administered intramuscularly for both adults and children, regardless of body weight, though in small children it may be calculated as 4.0 units/kg if needed 1, 2.
Key Dosing Information
Standard TIG Dose
- Fixed dose: 250 units IM for all patients (adults and pediatric) 1, 2
- Pediatric weight-based alternative: 4.0 units/kg 2
- However, it is advisable to administer the entire 250-unit dose regardless of the child's size, since theoretically the same amount of toxin will be produced by the tetanus organism in a child's body as in an adult's 2
Administration Technique
- Route: Deep intramuscular injection 2
- Critical requirement: When TIG and tetanus toxoid are given concurrently, use separate syringes and separate injection sites (different extremities) 1, 2
Clinical Decision Algorithm
For Tetanus-Prone Wounds
Step 1: Assess vaccination history
- Complete primary series confirmed + booster within 5 years → Tetanus toxoid only
- Complete primary series confirmed + no booster within 5 years → Tetanus toxoid only
- Incomplete or uncertain vaccination history → Both TIG (250 units) AND tetanus toxoid
Step 2: Identify high-risk patients for TIG priority (if supplies limited):
- Persons aged >60 years 1
- Immigrants from regions other than North America or Europe 1
- These groups are least likely to have adequate antitetanus antibodies
For Clean, Minor Wounds
- Booster only if no tetanus toxoid within 10 years 1
- TIG generally not indicated
Important Clinical Caveats
Common Pitfall: The dose is NOT weight-based in routine practice. While the FDA label mentions 4.0 units/kg as a calculation option for small children, the guideline recommendation is clear that 250 units should be given regardless of patient size 2. This is because the amount of toxin produced by Clostridium tetani is independent of the patient's body weight.
Timing consideration: TIG provides immediate passive immunity with peak blood levels achieved approximately 2 days after IM injection, with a half-life of approximately 23 days 2. This bridges protection while active immunity from tetanus toxoid develops.
Interference with active immunization: While some older research suggested that higher doses of TIG (400-500 units) might slightly suppress the immune response to concurrent tetanus toxoid 3, 4, 5, the standard 250-unit dose does not clinically impair the development of active immunity when given simultaneously with toxoid 4.
Treatment of Active Tetanus
For active tetanus cases (not prophylaxis), dosing should be adjusted according to severity of infection, with doses ranging from 3,000 to 6,000 units reported in historical studies 2, 5. However, optimal therapeutic dosing remains uncertain 2.
Alternative if TIG unavailable: Intravenous immune globulin (IVIG) may be substituted when passive protection is clearly indicated but TIG is unavailable 1.